Acute post-infusion hypokalemia following rituximab therapy in patients with nephrotic syndrome: case series and literature review
Severe hypokalemia can occur acutely after rituximab infusion in NS, even after prior uneventful exposures. Presentations may be delayed and nonspecific. Clinicians should monitor serum potassium before and after rituximab administration to enable timely recognition and management of this rare complication.
Authors
- Lie Jin (ORCID: https://orcid.org/0000-0002-8307-0228)
- Weidong Huang (ORCID: https://orcid.org/0009-0001-4151-5006)
- Y. Xu (ORCID: https://orcid.org/0009-0006-8553-9903)
- Fengfen Wu
- Tingyan Xiang (ORCID: https://orcid.org/0009-0003-3132-4374)
- Lishi Yu (ORCID: https://orcid.org/0000-0002-2790-4697)
- Wenhui Lei
Institutions
- Xinjiang Medical University (CN)
- Wenzhou Medical University (CN)
- First Affiliated Hospital of Wenzhou Medical University (CN)
- Fifth Affiliated Hospital of Xinjiang Medical University (CN)
- ShenZhen People’s Hospital (CN)
- Community Health Center (US)
Publication Details
- Journal
- Frontiers in Pharmacology
- Published
- 2026-02-27
- DOI
- https://doi.org/10.3389/fphar.2026.1770911
- Primary Topic
- Renal Diseases and Glomerulopathies
- Type
- article
- Field-Weighted Citation Impact
- 0.00